Delirium and agitation in traumatic brain injury patients: an update on pathological hypotheses and treatment options

Traumatic brain injury (TBI) is a global public health epidemic. It represents the principal cause of death and disability in individuals under 35 in the United States. In the subacute phase, severe TBI patients who recover consciousness go through a state of agitation and delirium. However, there i...

Full description

Bibliographic Details
Main Authors: Ganau, M, Lavinio, A, Prisco, L
Format: Journal article
Language:English
Published: Edizioni Minerva Medica 2018
_version_ 1797072074887397376
author Ganau, M
Lavinio, A
Prisco, L
author_facet Ganau, M
Lavinio, A
Prisco, L
author_sort Ganau, M
collection OXFORD
description Traumatic brain injury (TBI) is a global public health epidemic. It represents the principal cause of death and disability in individuals under 35 in the United States. In the subacute phase, severe TBI patients who recover consciousness go through a state of agitation and delirium. However, there is only limited research exploring the characteristics of post-traumatic delirium (PTD) although it is likely to be more frequent than in general Intensive Care Unit (ICU) patients. Evidence suggest the incidence of delirium in non-TBI ICU patients is up to 86%. The exact pathophysiological mechanisms underlying the development and progression of delirium in critically ill patients is still unclear. Many hypotheses have been proposed to play a role: neuroinflammation, neurotransmitter imbalance, structural and functional brain damage. TBI patients are at high risk of post-traumatic cognitive impairment, and up to two thirds of patients who survive TBI develop agitation and delirium which is associated with increased disability and long term cognitive impairment. Recommendation for the treatment of PTD in patients admitted to ICU are not clearly identified. Despite the high prevalence of PTD, the condition often goes misrecognised and attributed primarily to the injury itself. There is increasing evidence that certain drugs such as antipsychotics can reduce the incidence and severity of delirium, whereas other drugs such as dexmedetomidine and remifentanil are associated with decreased risk of developing delirium in general ICU patients. However, there is a lack of high quality studies exploring treatment strategies for PTD in the acute setting.
first_indexed 2024-03-06T23:02:24Z
format Journal article
id oxford-uuid:62988773-cf30-449d-8ca9-10987c064a11
institution University of Oxford
language English
last_indexed 2024-03-06T23:02:24Z
publishDate 2018
publisher Edizioni Minerva Medica
record_format dspace
spelling oxford-uuid:62988773-cf30-449d-8ca9-10987c064a112022-03-26T18:07:14ZDelirium and agitation in traumatic brain injury patients: an update on pathological hypotheses and treatment optionsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:62988773-cf30-449d-8ca9-10987c064a11EnglishSymplectic Elements at OxfordEdizioni Minerva Medica2018Ganau, MLavinio, APrisco, LTraumatic brain injury (TBI) is a global public health epidemic. It represents the principal cause of death and disability in individuals under 35 in the United States. In the subacute phase, severe TBI patients who recover consciousness go through a state of agitation and delirium. However, there is only limited research exploring the characteristics of post-traumatic delirium (PTD) although it is likely to be more frequent than in general Intensive Care Unit (ICU) patients. Evidence suggest the incidence of delirium in non-TBI ICU patients is up to 86%. The exact pathophysiological mechanisms underlying the development and progression of delirium in critically ill patients is still unclear. Many hypotheses have been proposed to play a role: neuroinflammation, neurotransmitter imbalance, structural and functional brain damage. TBI patients are at high risk of post-traumatic cognitive impairment, and up to two thirds of patients who survive TBI develop agitation and delirium which is associated with increased disability and long term cognitive impairment. Recommendation for the treatment of PTD in patients admitted to ICU are not clearly identified. Despite the high prevalence of PTD, the condition often goes misrecognised and attributed primarily to the injury itself. There is increasing evidence that certain drugs such as antipsychotics can reduce the incidence and severity of delirium, whereas other drugs such as dexmedetomidine and remifentanil are associated with decreased risk of developing delirium in general ICU patients. However, there is a lack of high quality studies exploring treatment strategies for PTD in the acute setting.
spellingShingle Ganau, M
Lavinio, A
Prisco, L
Delirium and agitation in traumatic brain injury patients: an update on pathological hypotheses and treatment options
title Delirium and agitation in traumatic brain injury patients: an update on pathological hypotheses and treatment options
title_full Delirium and agitation in traumatic brain injury patients: an update on pathological hypotheses and treatment options
title_fullStr Delirium and agitation in traumatic brain injury patients: an update on pathological hypotheses and treatment options
title_full_unstemmed Delirium and agitation in traumatic brain injury patients: an update on pathological hypotheses and treatment options
title_short Delirium and agitation in traumatic brain injury patients: an update on pathological hypotheses and treatment options
title_sort delirium and agitation in traumatic brain injury patients an update on pathological hypotheses and treatment options
work_keys_str_mv AT ganaum deliriumandagitationintraumaticbraininjurypatientsanupdateonpathologicalhypothesesandtreatmentoptions
AT lavinioa deliriumandagitationintraumaticbraininjurypatientsanupdateonpathologicalhypothesesandtreatmentoptions
AT priscol deliriumandagitationintraumaticbraininjurypatientsanupdateonpathologicalhypothesesandtreatmentoptions